Polygenic risk score
Borderline Personality Disorder
ICD-11 6D10.5 · Personality disorders
The Borderline Personality Disorder polygenic risk score summarizes common-variant liability for BPD. BPD genetics is a newer area with smaller cohorts than most psychiatric traits — the score is less well-powered and should be interpreted accordingly.
BPD shares substantial common-variant architecture with MDD, PTSD, and bipolar disorder — reflecting emotional-dysregulation and trauma-response axes that cross traditional diagnostic lines.
At a glance
Borderline personality disorder (BPD) is heritable (~40-60%) and genetically correlated with mood and anxiety disorders. This 2025 GWAS is the first well-powered BPD polygenic study.
Borderline personality disorder is characterized by persistent patterns of emotional instability, unstable self-image, impulsivity, and difficulty maintaining relationships. The 2025 PGC-BPD GWAS analyzed ~12,000 cases and over 1 million controls — the first well-powered genetic study of BPD. Common variants explain an estimated 20% of BPD liability (h²_SNP).
What the GWAS actually found
Borderline Personality Disorder GWAS are newer and smaller than for most PGC-covered conditions. Recent analyses identify loci implicated in emotional regulation and impulse control, with substantial common-variant overlap with MDD, PTSD, and bipolar disorder.
Twin-study heritability for BPD sits at roughly 0.40–0.55. The architecture appears to sit at the intersection of mood, trauma-response, and personality-trait genetics — consistent with clinical observations of high comorbidity and trauma-history overlap.
Full citation: Streit F, et al. (2025). Genome-wide association study of borderline personality disorder identifies three loci. Molecular Psychiatry (in press). 12,339 cases, 1,041,717 controls.
How to read your percentile
Below 25th
Lower common-variant liability than most of the reference cohort. BPD remains possible regardless of PRS — childhood trauma and attachment disruption are major independent contributors.
25th–75th
Typical range — near the population average. PRS is especially underpowered at this percentile given the smaller BPD cohort.
Above 75th
Elevated common-variant liability. Interpret with extra caution — the BPD PRS has more uncertainty than most psychiatric scores. Evidence-based therapy (DBT and related) is effective for BPD symptoms regardless of genetic risk.
What this does not tell you
A BPD PRS cannot diagnose BPD, distinguish BPD from complex PTSD (substantial clinical and genetic overlap), or predict treatment response. Dialectical Behavior Therapy (DBT) and related modalities have strong evidence bases — treatment, not genetics, is the actionable clinical question.
The BPD cohort is especially ancestry-skewed toward European participants; cross-ancestry accuracy is reduced. BPD classification itself is an area of active diagnostic debate (ICD-11 reframed personality disorders into a dimensional model); the PRS reflects the categorical definition used in the source GWAS.
Related traits
Borderline Personality Disorder shares common-variant architecture with several other psychiatric conditions. Genetic correlations (rg) reflect how often the same variants move risk for both traits in the same direction.
Frequently asked questions
How reliable is the BPD PRS?
Less reliable than most psychiatric PRS. The BPD GWAS cohort is smaller than for depression or schizophrenia, so individual percentiles carry more uncertainty. Treat the score as a weaker probabilistic signal than, say, the schizophrenia PRS.
Is BPD distinguishable from complex PTSD genetically?
Not cleanly with current GWAS. The clinical and genetic overlap between BPD and complex PTSD is substantial, and both conditions emerged from partially overlapping research traditions. Distinct PRS for BPD vs cPTSD is an open research question.
Does a high PRS mean I have BPD?
No. BPD diagnosis requires clinical evaluation of emotional regulation, interpersonal patterns, self-image, and impulsivity over time — not genetics. PRS is a population-level probabilistic signal.
What's the most useful thing I can do with this score?
Not very much, clinically. The BPD PRS is not clinically actionable at the individual level. If BPD symptoms are distressing, evidence-based therapy (DBT, mentalization-based therapy, schema therapy) is effective regardless of genetic risk profile.
Sources
- PGC Borderline Personality Disorder Working Group. pgc.unc.edu/for-researchers/working-groups/personality-disorders-workgroup/
Note: This trait references a recent or pre-publication GWAS. Specific cohort numbers, loci counts, and variance-explained estimates on this page will be refined when the final peer-reviewed source is published. The product uses summary statistics from the source cited above.
Want your own polygenic risk score?
Upload your AncestryDNA or 23andMe raw data to get the ADHD and Anxiety preview free, or unlock all 13 traits for $29 (launch pricing).
Upload your file